Published in Arch Surg on September 01, 2003
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol (2006) 3.37
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol (2012) 2.38
The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Ann Oncol (2012) 1.46
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol (2010) 1.38
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review. Indian J Surg Oncol (2011) 1.13
Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. Eur J Nucl Med Mol Imaging (2014) 1.04
Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer. Can J Surg (2006) 0.96
Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective analysis. PLoS One (2013) 0.92
Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma. World J Gastroenterol (2008) 0.92
Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma. Int J Clin Exp Pathol (2014) 0.90
Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients. Surg Today (2013) 0.89
Indications for staging laparoscopy in pancreatic cancer. HPB (Oxford) (2015) 0.87
Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma. Medicine (Baltimore) (2015) 0.87
Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer. World J Gastroenterol (2004) 0.84
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. J Gastrointest Oncol (2013) 0.83
Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study. World J Surg Oncol (2014) 0.79
Predicting distant metastasis in patients with suspected pancreatic and periampullary tumors for selective use of staging laparoscopy. World J Surg (2011) 0.78
Staging laparoscopy for proximal pancreatic cancer in a magnetic resonance imaging-driven practice: what's it worth? HPB (Oxford) (2011) 0.77
Is a preoperative assessment of the early recurrence of pancreatic cancer possible after complete surgical resection? Gut Liver (2013) 0.77
Preoperative Platelet-Lymphocyte Ratio Augments CA 19-9 as a Predictor of Malignancy in Chronic Calcific Pancreatitis. World J Surg (2015) 0.75
The Role of CA19-9 in Predicting Tumour Resectability in Carcinoma Head of Pancreas. J Clin Diagn Res (2016) 0.75
New tumor-associated antigen SC6 in pancreatic cancer. World J Gastroenterol (2005) 0.75
Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients. Oncol Lett (2016) 0.75
Metformin reduces serum CA199 levels in type 2 diabetes Chinese patients with time-effect and gender difference. Diabetes Technol Ther (2014) 0.75
Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma. Medicine (Baltimore) (2016) 0.75
Preoperative predictors for early recurrence of resectable pancreatic cancer. World J Surg Oncol (2017) 0.75
Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma. World J Clin Oncol (2017) 0.75
Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy. Int J Clin Oncol (2017) 0.75
Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients. J Gastrointest Surg (2017) 0.75
Morbidity, mortality, and technical factors of distal pancreatectomy. Am J Surg (2002) 2.03
Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res (2009) 1.88
Career and lifestyle satisfaction among surgeons: what really matters? The National Lifestyles in Surgery Today Survey. J Am Coll Surg (2009) 1.66
Women surgeons in the new millennium. Arch Surg (2009) 1.54
Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. Arch Surg (2002) 1.54
Experience and attitudes of surgeons toward palliation in cancer. Arch Surg (2005) 1.37
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase. Int J Cancer (2008) 1.36
Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. J Am Coll Surg (2004) 1.24
Immediate breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed. Arch Surg (2004) 1.23
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line. Cancer Chemother Pharmacol (2004) 1.20
Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother Pharmacol (2005) 1.19
Surgical resident involvement is safe for common elective general surgery procedures. J Am Coll Surg (2011) 1.17
ADI, autophagy and apoptosis: metabolic stress as a therapeutic option for prostate cancer. Autophagy (2009) 1.14
Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res (2009) 1.14
Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg (2009) 1.10
Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther (2002) 1.08
Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol (2010) 1.08
Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer (2008) 1.06
Hospital readmissions: necessary evil or preventable target for quality improvement. Ann Surg (2014) 1.05
Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment. Ann Surg Oncol (2003) 1.04
The role of Akt activation in the response to chemotherapy in pancreatic cancer. Anticancer Res (2010) 1.02
Acute appendicitis: is there a difference between children and adults? Am Surg (2006) 1.02
Systemic stress response after laparoscopic and open gastric bypass. J Am Coll Surg (2002) 1.01
Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg (2008) 1.00
Single-site robotic cholecystectomy in a broadly inclusive patient population: a prospective study. Ann Surg (2014) 0.99
Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg (2011) 0.99
Medullary carcinoma of the breast: a population-based perspective. Med Oncol (2011) 0.98
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer. Lung Cancer (2005) 0.98
Negligible effect of selective preoperative biliary drainage on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy. Arch Surg (2009) 0.97
Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol (2007) 0.95
Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer. J Surg Res (2003) 0.92
Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death. J Surg Res (2009) 0.92
Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy. Semin Oncol (2004) 0.90
Multimodality management of a giant cell tumor arising in the proximal sacrum: case report. Spine (Phila Pa 1976) (2002) 0.90
BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer. J Cell Biochem (2007) 0.89
A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. J Thorac Oncol (2007) 0.89
Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis. Cancer (2009) 0.89
Predicting survival for well-differentiated liposarcoma: the importance of tumor location. J Surg Res (2011) 0.88
ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis. J Surg Res (2008) 0.87
Expression of transforming growth factor beta1 in patients with and without previous abdominal surgery. Arch Surg (2003) 0.87
Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era. Med Oncol (2010) 0.86
Surgery in the aged population: surgical oncology. Arch Surg (2003) 0.86
Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg (2010) 0.86
Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res (2012) 0.86
Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma. J Surg Oncol (2014) 0.85
Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol (2010) 0.85
Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses. J Surg Oncol (2013) 0.84
A prospective, blinded trial of touch prep analysis versus frozen section for intraoperative evaluation of sentinel lymph nodes in breast cancer. Ann Surg Oncol (2008) 0.83
Effect of generational composition on the surgical workforce. Arch Surg (2008) 0.83
Perioperative care of the patient with hemophilia undergoing urgent appendectomy. Arch Surg (2007) 0.82
Negligible effect of perioperative epidural analgesia among patients undergoing elective gastric and pancreatic resections. J Gastrointest Surg (2013) 0.82
Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol Phys (2010) 0.81
Hematin is one of the cytotoxic factors in pancreatitis-associated ascitic fluid that causes hepatocellular injury. Surgery (2002) 0.81
Do radiation use disparities influence survival in patients with advanced breast cancer? Cancer (2011) 0.80
Ultrasonography and computed tomography in suspected acute appendicitis. Semin Ultrasound CT MR (2003) 0.80
Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Ann Surg Oncol (2006) 0.80
Targeting Bcl-2-mediated cell death as a novel therapy in pancreatic cancer. J Surg Res (2010) 0.79
Perioperative outcomes for open distal pancreatectomy: current benchmarks for comparison. J Gastrointest Surg (2011) 0.79
Symptomatic pancreatic polypeptide-secreting tumor of the distal pancreas (PPoma). Int J Gastrointest Cancer (2002) 0.79
Percutaneous transhepatic portography with intravascular ultrasonography for evaluation of venous involvement of hepatobiliary and pancreatic tumors. J Vasc Interv Radiol (2002) 0.79
Controlled tamponade of severe presacral venous hemorrhage: use of a breast implant sizer. Dis Colon Rectum (2002) 0.79
Rural-urban disparities in use of post-lumpectomy radiation. Med Oncol (2012) 0.78
Cost analysis of establishing a relationship between a surgical program in the US and Vietnam. Int Surg (2012) 0.77
Quantitative analysis of autophagy using advanced 3D fluorescence microscopy. J Vis Exp (2013) 0.77
An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer. Am J Surg (2005) 0.77
Factors affecting treatment delivery and outcomes of patients with early-stage pancreatic adenocarcinoma. Pancreas (2011) 0.77
Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer. Med Oncol (2011) 0.77
Mental health needs and service use in a national sample of adult cancer survivors in the USA: has psychosocial care improved? Psychooncology (2014) 0.77
A Systematic Review of Emergency Department Use Among Cancer Patients. Cancer Nurs (2016) 0.77
Extremity soft tissue tumor surgery by surgical specialty: a comparison of case volume among oncology and non-oncology-designated surgeons. J Surg Oncol (2013) 0.77
Role of autophagy in apoptotic regulation by Akt in pancreatic cancer. Anticancer Res (2014) 0.77
Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers. Expert Opin Investig Drugs (2015) 0.76
Re: CA 19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and preoperative therapy. Ann Surg Oncol (2013) 0.76
Proteasome inhibition in small-cell lung cancer: preclinical rationale and clinical applications. Clin Lung Cancer (2005) 0.76
Re: Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors, by Bufalari A, Giustozzi G, Burattini MF, et al. J Surg Oncol (2006) 0.75
Re: Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg (2002) 0.75
Clinical usefulness of a treatment algorithm for pancreatic pseudocysts. Gastrointest Endosc (2008) 0.75
Standardization of sentinel lymph node biopsy in breast carcinoma. Cancer (2005) 0.75
Text messaging among residents and faculty in a university general surgery residency program: prevalence, purpose, and patient care. J Surg Educ (2012) 0.75
Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy. Ann Surg Oncol (2012) 0.75
Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy. J Surg Res (2012) 0.75
Cost-Effectiveness Analysis and Volume-Based Surgical Care. J Am Coll Surg (2022) 0.75
Complex diaphragm reconstruction using dermal collagen matrix after multivisceral resection of retroperitoneal sarcoma. J Thorac Cardiovasc Surg (2009) 0.75
Surgical volunteerism in Vietnam: surgeons and educators strengthen the U.S.-Vietnam relationship. Bull Am Coll Surg (2011) 0.75
Bortezomib-based combinations in the treatment of non-small-cell lung cancer. Clin Lung Cancer (2005) 0.75